Utilizing daily interferon (alpha 2b) and ribavirin combination therapy in chronic hepatitis C: a preliminary report.

Z. Karasu, A. Gurakar, C. Emmett, A. Jazzar, G. McMillon, S. Hulagu, H. Wright

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Utilizing daily interferon (alpha 2b) and ribavirin combination therapy in chronic hepatitis C: a preliminary report.'. Together they form a unique fingerprint.

Medicine & Life Sciences